Accelerated phase of idiopathic pulmonary fibrosis

被引:2
|
作者
Urrengoetxea, Lander Altube [1 ]
Solano, Carlos Salinas [1 ]
Barrenetxea, Myriam Aburto [1 ]
Cortes, Francisco Javier Moraza [1 ]
Quincoces, Aitor Ballaz [1 ]
Sainz, Alberto Capelastegul [1 ]
机构
[1] Hosp Galdakao, Serv Neumol, Galdakao 48960, Vizcaya, Spain
来源
ARCHIVOS DE BRONCONEUMOLOGIA | 2007年 / 43卷 / 09期
关键词
accelerated phase; idiopathic pulmonary fibrosis; tumor markers;
D O I
10.1016/S1579-2129(07)60117-7
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The natural history of idiopathic pulmonary fibrosis is characterized by a slow progression resulting in respiratory failure and death. The progression to the fulminant form is rapid in a small percentage of cases, however. Within weeks or months, patients develop respiratory distress, and extensive ground-glass patterns can be seen in computed tomography scans and hyaline membranes in biopsy samples. This is described as an accelerated phase of idiopathic pulmonary fibrosis, in which elevated levels of acute-phase reactants and tumor markers have been reported. To date, the monoclonal tumor marker, CA 1513 has not been associated with the accelerated phase.
引用
收藏
页码:516 / 518
页数:3
相关论文
共 50 条
  • [1] Idiopathic Pulmonary Fibrosis Accelerated By Nitrofurantoin
    Ynosencio, T.
    Blough, B. A.
    Mora, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [2] CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis
    Akira, M
    Hamada, H
    Sakatani, M
    Kobayashi, C
    Nishioka, M
    Yamamoto, S
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1997, 168 (01) : 79 - 83
  • [3] Strongyloides stercoralis hyperinfection mimicking accelerated form of idiopathic pulmonary fibrosis
    Janssen, Rob
    Vlaminckx, Bart J. M.
    Seldenrijk, Cornelis A.
    Voorn, Geert P.
    Grutters, Jan C.
    LANCET INFECTIOUS DISEASES, 2008, 8 (07): : 456 - 456
  • [4] Phase three clinical trials in idiopathic pulmonary fibrosis
    Sgalla, Giacomo
    Lerede, Marialessia
    Richeldi, Luca
    EXPERT OPINION ON ORPHAN DRUGS, 2021, 9 (01): : 1 - 11
  • [5] Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
    Strykowski, Rachel
    Adegunsoye, Ayodeji
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2023, 43 (02) : 209 - 228
  • [6] Accelerated Variant of Idiopathic Pulmonary Fibrosis: Clinical Behavior and Gene Expression Pattern
    Selman, Moises
    Carrillo, Guillermo
    Estrada, Andrea
    Mejia, Mayra
    Becerril, Carina
    Cisneros, Jose
    Gaxiola, Miguel
    Perez-Padilla, Rogelio
    Navarro, Carmen
    Richards, Thomas
    Dauber, James
    King, Talmadge E., Jr.
    Pardo, Annie
    Kaminski, Naftali
    PLOS ONE, 2007, 2 (05):
  • [7] IDIOPATHIC PULMONARY FIBROSIS
    SELMAN, M
    REVISTA MEDICA DE CHILE, 1985, 113 (03) : 260 - 263
  • [8] Idiopathic pulmonary fibrosis
    Harari, S
    Caminati, A
    ALLERGY, 2005, 60 (04) : 421 - 435
  • [9] IDIOPATHIC PULMONARY FIBROSIS
    PARIENTE, R
    GAZETTE MEDICALE, 1985, 92 (03): : 51 - &
  • [10] Idiopathic Pulmonary Fibrosis
    Prasse, A.
    PNEUMOLOGIE, 2015, 69 (10): : 608 - 614